June 10, 2022

Cancer Institute Retreat Highlights Novel Therapeutic Targets and Agents

Marty Trieschmann

Jungang Chen, a postdoctoral fellow in the UAMS Department of Pathology, discusses his research on pathogenesis and tumorgenesis in Covid-19 patients infected with Herpes

The Winthrop P. Rockefeller Cancer Institute held its second annual scientific research retreat May 26 at the Marriott Hotel in Little Rock. More than 140 scientists gathered in person for the first time in two years. The retreat theme, “Molecular Targets and Cancer Therapeutics,” reflects the growth in the identification of new and novel molecular…

June 9, 2022

Arkansas Undergraduates ‘Speed Date’ with Research at UAMS Obesity and Diabetes Workshop

Seth Hooker

UAMS’ Emir Tas, M.D., (left) leads a table discussion about fatty liver disease and the benefits of high-intensity interval training.

The University of Arkansas for Medical Sciences (UAMS) presented undergraduate students with an opportunity to learn more about obesity and diabetes at a uniquely structured workshop May 25. The workshop, hosted by Arkansas INBRE (IDeA Network of Biomedical Research Excellence), was attended by 15 students from around the state. There were presentations from seven UAMS…

June 7, 2022

UAMS, CAVHS Studying Health Effects of Arkansas Veterans’ Exposure to Burn Pits in Middle East

David Robinson

U.S. Marines with 1st Marine Logistics Group view burn pit at Al Taqaddum Air Base, Iraq, Sept. 22, 2008.

LITTLE ROCK — More than 300 Arkansas veterans will become part of a new study conducted by the University of Arkansas for Medical Sciences (UAMS) and the Central Arkansas Veterans Healthcare System (CAVHS) to determine if exposure to open pit burning and molecular-level changes are associated with chronic health conditions. The Department of Veterans Affairs…

June 2, 2022

UAMS Study First to Test When Common Arsenic Exposures Are Most Likely to Cause Male Infertility in Offspring

David Robinson

Shuk-Mei Ho, Ph.D., and Yuet-Kin "Ricky" Leung, Ph.D., are leading the five-year, $2.54 million arsenic study.

LITTLE ROCK — In the first study of its kind, researchers at the University of Arkansas for Medical Sciences (UAMS) will test when exposure to inorganic arsenic —  a common, harmful environmental toxin — is most likely to lead to infertility traits that may last for generations. The study, supported by a five-year, $2.54 million…

June 1, 2022

Study Shows That Arkansas Minorities Experienced Abnormally High Rates of COVID-19 Infection

Kev' Moye

COVID-19 Vaccination

LITTLE ROCK — Researchers from multiple Arkansas agencies conducted an eight-month study which revealed that the state’s Hispanic and Black populations had higher COVID-19 infection rates than whites. This project, which Open Forum Infectious Disease published, used seroprevalence of antibodies to COVID-19 as an indicator. Antibodies are created by a person’s immune system once they…

May 26, 2022

Four UAMS Faculty Receive 2022 Provost’s Innovator Awards

David Robinson

The awardees are Lisa Brents, Ph.D., Lyle Burdine, M.D., Ph.D., Craig Forrest, Ph.D., and Gresham Richter, M.D.

The University of Arkansas for Medical Sciences (UAMS) announced four UAMS faculty as recipients of the Provost’s Innovator Awards. The awards were established by Stephanie Gardner, Pharm.D., Ed.D., UAMS provost and chief strategy officer, and Shuk-Mei Ho, Ph.D., vice chancellor for Research and Innovation. The grants of $25,000 each support groundbreaking, innovative, high-impact projects that…

May 23, 2022

UAMS Begins Final Study of First Rapid Test for Acetaminophen Toxicity with $3.2 Million Grant

David Robinson

Laura James, M.D., hopes the final phase of research will lead to FDA approval of the rapid test for acetaminophen toxicity.

The first rapid diagnostic test for acetaminophen toxicity has cleared a major hurdle on its long road to the marketplace from UAMS.

May 20, 2022

ARresearch Study Participants Celebrated on Clinical Trials Day

David Robinson

Nathaniel Noble, an ARresearch volunteer, discusses a study with UAMS' Giuseppina “Giusy” Dusio, Ph.D., in this file photo.

As part of international Clinical Trials Day 2022, research leaders saluted the more than 8,400 Arkansas volunteers in the ARresearch registry at UAMS.

May 19, 2022

UAMS Study Found Large Segment of Arkansans Still Susceptible to COVID-19 in Late 2020, 2021

Kev' Moye

Victor Cardenas

LITTLE ROCK — A team of scientists at the University of Arkansas for Medical Sciences (UAMS) carried out an eight-month seroprevalence survey that found 85% of the state’s population was still susceptible to the virus in late 2020. This project – which the Public Library of Science ONE recently published – focused on the number…

May 16, 2022

UAMS Infectious Disease Researchers Awarded $5.7 Million COBRE Grant Extension

Linda Satter

UAMS’ Mark Smeltzer, Ph.D., first secured a Centers for Biomedical Research Excellence (COBRE) program grant in 2012 and will lead the program through its final phase.

LITTLE ROCK — The National Institute of General Medical Sciences within the National Institutes of Health awarded an additional $5.7 million, five-year grant to fund the third and final phase of a University of Arkansas for Medical Sciences program that supports infectious disease research. This final phase of the Centers for Biomedical Research Excellence (COBRE)…

Previous page Next page